Table 1.
Baseline characteristics for patients enrolled.
| Group | Age | Sex | Disease duration | LEDD | MDS-UPDRS III | H&Y stage | WS | BS | Axial | Tremor | Rigidity |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Levels | Mean years (SD) | M/F | Mean years (SD) | Mean mg (SD) | Mean score (SD) | Median score (IQR) | Mean score (SD) | Mean score (SD) | Median score (IQR) | Mean score (SD) | Mean score (SD) |
| Real (n = 39) | 62 (9) | 27/12 | 6.7 (3.8) | 627 (317) | 40.7 (10.6) | 2.0 (2.0–2.0) | 17.0 (4) | 11.2 (4.3) | 8.0 (6.0–10.0) | 8.5 (5.1) | 7.7 (3.5) |
| M1-PFC (n = 19) | 63.9 (10) | 12/7 | 7.6 (4.9) | 585.1 (304) | 42.4 (11.2) | 2.0 (2.0–2.5) | 17.5 (3.3) | 11.8 (4.3) | 8.0 (6.5–11.0) | 7.3 (3.9) | 8.5 (2.9) |
| M1 (n = 20) | 60.4 (8.1) | 15/5 | 5.8 (2.1) | 666.9 (332) | 39.1 (10) | 2.0 (2.0–2.0) | 16.7 (4.7) | 10.7 (4.4) | 8.0 (6.0–10.0) | 9.7 (5.9) | 7.1 (4) |
| Sham (n = 20) | 64.2 (5.5) | 14/6 | 7.2 (3) | 629.2 (315) | 43.3 (9) | 2.0 (2.0–2.0) | 17.1 (4) | 12.2 (3.1) | 8.0 (4.0–10.5) | 6.6 (3.2) | 8.5 (3.7) |
| P | 0.36 | 0.65 | 0.98 | 0.34 | 0.14 | 0.94 | 0.38 | 0.04 | 0.14 | 0.41 |
LEDD, Levodopa Equivalent Daily Dose; UPDRSIII, Unified Parkinson's Disease Rating Scale part III; H&Y, Hoen and Yahr stage; WS, worse side subscore; BS, better side subscore; SD, standard deviation; IQR, interquartile range.